SCHEMBL3049032

SCHEMBL3049032

COC(=O)C(=Cc1ccc(OC)c(OC)c1)c1ccc(OC)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.63
TNFRSF1A P19438 2/20 0.59
PDE4A P27815 2/20 0.56
PDE4B Q07343 2/20 0.56
PDE4C Q08493 2/20 0.56
PDE4D Q08499 2/20 0.56
AKR1C3 P42330 1/20 0.56
ABCG2 Q9UNQ0 3/20 0.56
ALDH1A1 P00352 3/20 0.54
GAA P10253 2/20 0.54
TUBB4A P04350 1/20 0.53
TUBB P07437 1/20 0.53
TUBA3C P0DPH7 1/20 0.53
TUBA1B P68363 1/20 0.53
TUBA4A P68366 1/20 0.53
TUBB4B P68371 1/20 0.53
TUBB3 Q13509 1/20 0.53
TUBB2A Q13885 1/20 0.53
TUBB8 Q3ZCM7 1/20 0.53
TUBA3E Q6PEY2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3051689 1.00 NQO2 (0.63) NQO2TNFRSF1APDE4APDE4BPDE4C
SCHEMBL30159756 0.92 ABCG2 (0.59) NQO2TNFRSF1APDE4APDE4BPDE4C
SCHEMBL12507687 0.92 ABCG2 (0.59) NQO2TNFRSF1APDE4APDE4BPDE4C
SCHEMBL14125392 0.89 CXCL12 (0.61) NQO2ABCG2ALDH1A1GAATDP1
SCHEMBL14125391 0.89 CXCL12 (0.61) NQO2ABCG2ALDH1A1GAATDP1
SCHEMBL28673508 0.89 AKR1C3 (0.53) NQO2AKR1C3ABCG2ALDH1A1GAA
SCHEMBL28103395 0.89 GAA (0.56) NQO2TNFRSF1AAKR1C3ABCG2ALDH1A1
SCHEMBL3047082 0.87 AKR1C3 (0.72) NQO2TNFRSF1APDE4APDE4BPDE4C
SCHEMBL3047079 0.87 AKR1C3 (0.72) NQO2TNFRSF1APDE4APDE4BPDE4C
SCHEMBL28673604 0.81 PDE4A (0.53) NQO2TNFRSF1APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476255-B2 Histone deacetylase inhibitors ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2013-07-02 US disclosed
US-20100222379-A1 NOVEL HISTONE DEACETYLASE INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2010-09-02 US disclosed
EP-2205563-A2 NOVEL HISTONE DEACETYLASE INHIBITORS Orchid Research Laboratories Limited (IN) 2010-07-14 EP disclosed
WO-2009047615-A2 NOVEL HISTONE DEACETYLASE INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2009-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222379-A1 NOVEL HISTONE DEACETYLASE INHIBITORS HDAC5, HDAC2, HDAC1 NQO2 1169/4885TNFRSF1A 1516/4885PDE4A 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.